DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Balko JM, Giltnane JM, Wang K. et al.
Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets.
Cancer Discov 2014;
4: 232-245
We do not assume any responsibility for the contents of the web pages of other providers.